5[1]Brogden RN, Heel RC, Pakes GE. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain varying origin[J]. Drug, 1980;20(1):24
6[2]Terhaag B, Hoffmann A, Barkworth M, Vens-Cappell B. Bioavailability of a new effervescent tablet of diclofenac [ J ]. Int J Clin Pharmacol Ther, 2000;38(11) :546 - 51
7[5]Walter K, von Nieciecki A. Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets [ J ]. Arzneimittelforschung, 2001;51(8) :643 - 50
8[6]Zmeili S, Hasan M, Najib N, Sallam E, Deleq S, Shubair M.Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, voltaren vs inflaban:effect of food on inflaban bioavailibility[J]. Int J Clin Pharmacol Ther, 1996;34(12) :564- 70
9[7]Raz I, Hussein Z, Samara E, Ben-David J. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects[J]. Int J Clin Pharmacol Ther Toxicol, 1988;26(5) :246 - 8
